Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000935836-25-000373·LYTTON LAURENCE W
Schedule 13G ownership disclosure
NEUROONE MED TECHNOLOGIES CO
Common Stock, par value $0.001 · CUSIP: 64130M209
Event date: 2025-03-31
- Filing-level shares
- 1,295,288.00
- Percent of class
- 2.6%
- LYTTON LAURENCE W
Shares: 1,295,288.00 · Class: 2.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-25-000373
- Form type
- SCHEDULE 13G/A
- Filer
- LYTTON LAURENCE W
- CIK
- CIK 1105806
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership